Early results of a phase I trial of oblimersen sodium for relapsed or refractory Waldenström's macroglobulinemia

Morie A. Gertz, Susan M. Geyer, Ashraf Badros, Brad S. Kahl, Charles Erlichman

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Early results of a phase I trial of oblimersen sodium for relapsed or refractory Waldenström's macroglobulinemia'. Together they form a unique fingerprint.

Medicine & Life Sciences